Spago Nanomedical AB SPAGO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- SEK 0.10
- Day Range
- SEK 0.10–0.10
- 52-Week Range
- SEK 0.08–0.26
- Bid/Ask
- SEK 0.10 / SEK 0.11
- Shares Outstanding
- 798.38M
- Market Cap
- SEK 82.23M
- Volume/Avg
- 19,106 / 279,308
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1,561.54
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Spago Nanomedical AB is a nanomedicine company in the field of cancer diagnosis and treatment. The company's product includes SpagoPix and Tumorad. The SpagoPix product aims to improve cancer diagnosis with magnetic resonance imaging through the previous detection of tumors and metastases. The Tumorad products focus on the development of a completely new form of radionuclide therapy for tumor-selective radiation therapy of cancer. The company's development projects are based on a platform of polymeric materials with various properties for the precise diagnosis and treatment of life-threatening and debilitating diseases.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 6
- Website
- https://www.spagonanomedical.se
Valuation
|
Metric
|
SPAGO
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.56 |
Price/Sales | 1,561.54 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
SPAGO
|
|---|---|
Quick Ratio | 7.10 |
Current Ratio | 7.25 |
Interest Coverage | — |
Quick Ratio
SPAGO
Profitability
|
Metric
|
SPAGO
|
|---|---|
Return on Assets (Normalized) | −90.28% |
Return on Equity (Normalized) | −111.79% |
Return on Invested Capital (Normalized) | −113.72% |
Return on Assets
SPAGO
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|m>y<#V | LOCK|#>!X | $129B | |||
| Moderna Inc
MRNA
| LOCK|Dh^xgp$ | LOCK|g! | $90B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|^p@kr> | LOCK|Tb<&^ | $77B | |||
| argenx SE ADR
ARGX
| LOCK|F^@>q&B | LOCK|nCz | $51B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|!@d@&F | LOCK|lS< | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|^B!H>q^ | LOCK|>?cm | $31B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|X?L?&SmK | LOCK|>#<>G | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|TLSB%N | LOCK|>L? | $24B | |||
| Incyte Corp
INCY
| LOCK|<HKS#n | LOCK|^S | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|!YBDXs | LOCK|>@ | $14B |
United States